Rekvina Laboratories Limited

Equities

VINRKLB

INE092O01028

Market Closed - Bombay S.E. Other stock markets 03:30:54 13/12/2021 pm IST			5-day change	1st Jan Change
4.5 ^INR	-.--%		-.--%	-.--%

11/06	Rekvina Laboratories Limited Announces Resignation of Surbhit Shah as Company Secretary	CI
11/06	Rekvina Laboratories Limited Appoints Srishty Bansal as Company Secretary and Compliance Officer	CI

Rekvina Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023

May 30, 2023 at 08:57 pm IST

Rekvina Laboratories Limited reported earnings results for the full year ended March 31, 2023. For the full year, the company reported revenue was INR 0.037618 million. Net loss was INR 0.007452 million compared to INR 0.78881 million a year ago.

Latest news about Rekvina Laboratories Limited

Rekvina Laboratories Limited Announces Resignation of Surbhit Shah as Company Secretary	11/06	CI
Rekvina Laboratories Limited Appoints Srishty Bansal as Company Secretary and Compliance Officer	11/06	CI
Rekvina Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	30/05	CI
Rekvina Laboratories Limited Appoints Pravin Chauhan as the Chief Financial Officer	22/05	CI
Rekvina Laboratories Limited Announces Management Changes	22/05	CI
Rekvina Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02	CI
Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11	CI
Rekvina Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/23/11	CI
Rekvina Laboratories Trims Net Loss in Fiscal Q4	08/23/08	MT
Rekvina Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30/23/30	CI
Rekvina Laboratories Limited Appoints Bhavesh Prabhudas Vora as Non Executive, Additional Independent Director	14/22/14	CI
Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/22/14	CI
Rekvina Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	07/22/07	CI
Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	11/21/11	CI
Rekvina Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	23/21/23	CI
Rekvina Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	16/21/16	CI
Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	18/20/18	CI
Rekvina Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	06/20/06	CI
Rekvina Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	14/20/14	CI
Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019	14/19/14	CI
Rekvina Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	26/19/26	CI
Rekvina Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2019	12/19/12	CI
Rekvina Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2018	14/19/14	CI
Rekvina Laboratories Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2018	05/18/05	CI
Rekvina Laboratories Limited Announces Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2018	30/18/30	CI